Fulcrum Therapeutics, Inc. (FULC)

10.92 -0.39 (-3.45%) USD  |  NASDAQ  |  Jan 02, 16:00
10.90 -0.02 (-0.14%) After-Hours: 20:00
More

Fulcrum Therapeutics EPS Diluted (TTM): -1.179 for Sept. 30, 2025

EPS Diluted (TTM) Chart

View EPS Diluted (TTM) for FULC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
Agios Pharmaceuticals, Inc. -6.956
Biogen, Inc. 10.97
CorMedix, Inc. 2.053
Apellis Pharmaceuticals, Inc. 0.297
NovaBay Pharmaceuticals, Inc. 0.5953